Reference Ranges and Interpretation for Routine Adult Laboratory Tests

Hematology

• Anemia thresholds – Define anemia as hemoglobin < 13.5 g/dL in adult males and < 12.0 g/dL in adult females; no downward age‑adjustment is recommended because lower values in older men often reflect underlying pathology. American Society of Nephrology recommendation. 1
• Normal hemoglobin ranges – Adult males 13.5–17.5 g/dL; adult females 12.0–16.0 g/dL. [1][2]
• Normal hematocrit ranges – Males 40–52 %; females 36–48 %. 2
• Absolute neutrophil count (ANC) eligibility – An ANC > 1,500/µL excludes individuals with benign ethnic neutropenia; lowering the eligibility threshold to ≥1,000/µL is more appropriate for diverse populations. Clinical Cancer Research guidance. 3
• Platelet age‑related decline – Platelet count falls by ≈20,000/µL between the sixth and eighth decades of life. 3

Glucose Metabolism

• HbA1c reference interval – 4.0–6.0 % (20–42 mmol/mol) with a population mean of ≈5.0 % (31 mmol/mol). 4
• HbA1c categories – 5.7–6.4 % (39–47 mmol/mol) indicates pre‑diabetes; ≥6.5 % (≥48 mmol/mol) defines diabetes. 4
• Assay standards – HbA1c methods must be NGSP‑certified and traceable to the DCCT reference; point‑of‑care devices are not suitable for diagnostic use. American Diabetes Association recommendation. 4
• Reference interval precision – Intervals should not deviate >0.5 % from the mean (i.e., 4.5–5.5 %). 4
• Analytical variability – Changes of ±0.3 % may reflect assay variability rather than true glycemic change. 4
• Conditions affecting reliability – HbA1c is unreliable in anemia, hemoglobinopathies, end‑stage renal disease on dialysis, and any disorder altering red‑cell lifespan. 5
• Glycated albumin – Reference range 11–17 %; unreliable in nephrotic syndrome, cirrhosis, abnormal thyroid function, and disorders modifying albumin turnover. 5

Renal Function

• Serum creatinine reference – Males 0.7–1.3 mg/dL; females 0.5–1.1 mg/dL; Asian females 0.43–0.88 mg/dL (lower than White females). 3
• GFR estimation limitation – Cockcroft‑Gault and similar formulas tend to underestimate true creatinine clearance, especially in females and individuals with low muscle mass. 3
• Cancer‑population renal function – Approximately 50 % have creatinine clearance < 90 mL/min and 20 % < 60 mL/min. 3

Liver Function

• Alanine aminotransferase (ALT) – Normal range: males 10–79 U/L; females 10–55 U/L. 3
• Aspartate aminotransferase (AST) – Normal range: males 10–40 U/L; females 10–35 U/L. 3
• Transaminase eligibility in trials – Thresholds of 2–2.5 × ULN exclude many patients with adequate hepatic function; FDA guidance permits inclusion of patients with elevations up to 20 × ULN without compromising safety. FDA recommendation. 3
• Total bilirubin – 0.3–1.2 mg/dL; males have modestly higher concentrations than females. 3
• Alkaline phosphatase (ALP) – 30–120 U/L (age‑ and gender‑specific); increases ≈20 % between the third and eighth decades. 3

Thyroid Function

• TSH reference interval – 0.4–4.12 mIU/L (NHANES III data). American College of Endocrinology guideline. [6][7]
• Population mean/median – Approximately 1.5 mIU/L. 6
• Upper‑limit controversy – Proposing 2.5–3.0 mIU/L would generate >10 million additional hypothyroidism diagnoses in the U.S. without clear clinical benefit; therefore the broader 0.4–4.0 mIU/L range is retained across adult ages. [6][7]
• Levothyroxine treatment target – Aim for TSH within the normal range (0.45–4.12 mIU/L); no evidence supports targeting low‑normal or sub‑normal values. 6

Lipid Panel

• Total cholesterol – Desired < 200 mg/dL (< 5.2 mmol/L). 5
• LDL cholesterol – < 100 mg/dL (< 2.6 mmol/L) for adults without ASCVD; < 70 mg/dL (< 1.8 mmol/L) for those with ASCVD. 5
• HDL cholesterol – ≥ 40 mg/dL (≥ 1.0 mmol/L) in males; ≥ 50 mg/dL (≥ 1.3 mmol/L) in females; ≤ 35 mg/dL (≤ 0.91 mmol/L) increases diabetes and cardiovascular risk. 5
• Triglycerides – < 150 mg/dL (< 1.7 mmol/L); ≥ 200 mg/dL (≥ 2.22 mmol/L) is a diabetes risk factor. 5
• Racial differences – Black participants have significantly lower total cholesterol and triglycerides and higher HDL compared with White participants. 3

Prostate‑Specific Antigen (PSA)

• Age‑ and ethnicity‑specific upper limits –
  
  • 40–49 yr: ≤ 2.0 ng/mL (Asian‑American, African‑American); ≤ 2.5 ng/mL (White).
  • 50–59 yr: ≤ 3.0 ng/mL (Asian‑American); ≤ 4.0 ng/mL (African‑American); ≤ 3.5 ng/mL (White).
  • 60–69 yr: ≤ 4.0 ng/mL (Asian‑American); ≤ 4.5 ng/mL (African‑American & White).
  • 70–79 yr: ≤ 5.0 ng/mL (Asian‑American); ≤ 5.5 ng/mL (African‑American); ≤ 6.5 ng/mL (White).
    Urology Society recommendation. 8
• Median PSA values by decade – 0.7 ng/mL (40s), 0.9 ng/mL (50s), 1.2 ng/mL (60s), 1.5 ng/mL (70s). 8

Special Considerations

Altitude Adjustment for Hemoglobin

• Hemoglobin rises ≈0.6 g/dL in women and ≈0.9 g/dL in men for each 1,000 m above sea level; practical adjustments: +0.2 g/dL at 1,000 m, +0.8 g/dL at 2,000 m, +1.9 g/dL at 3,000 m. American Society of Nephrology guidance. [1][2]

Racial/Ethnic Laboratory Variability

• Among 38 standard laboratory tests in NHANES, only five (glucose, phosphorus, potassium, total bilirubin, uric acid) showed no significant racial/ethnic differences. Black participants exhibit higher creatine phosphokinase, globulin, total protein, and lower hematocrit, hemoglobin, total cholesterol, triglycerides, and white‑blood‑cell count compared with Whites. Clinical Cancer Research findings. 3
• The lower limit of normal hemoglobin for Black women is 9.6 g/dL, which is below many clinical‑trial eligibility thresholds. 3

Verification of Extreme HbA1c Values

• HbA1c results < 4 % (20 mmol/mol) or > 15 % (140 mmol/mol) should be confirmed by repeat testing, preferably using an assay based on a different analytical principle. American Diabetes Association recommendation. 4

Reference Ranges and Interpretation for Routine Adult Blood Chemistry Tests

Glucose Metabolism

• Fasting plasma glucose – Values < 100 mg/dL are considered normal, 100–125 mg/dL indicate pre‑diabetes, and ≥ 126 mg/dL on two separate occasions diagnose diabetes in non‑pregnant adults. 9
• HbA1c – The typical reference range is 4.0–6.0 % (20–42 mmol/mol) with a mean ≈ 5 % (31 mmol/mol); values ≥ 6.5 % (48 mmol/mol) are diagnostic for diabetes. [9][10]11
• Glycated albumin (GA) – Reference intervals are 10.8–17.1 % in Chinese populations and 11.9–16.9 % in other Asian cohorts; GA reflects glycaemia over the preceding 2–3 weeks. [12][13]

Renal Function

• Serum creatinine – Gender‑specific reference ranges are required; multiplying male values by 0.68 yields a sex‑independent range. [14][15]
• Blood urea nitrogen (BUN) – BUN concentrations vary with age and hydration status; laboratories should interpret results in the clinical context of these factors. 16
• Urine albumin‑to‑creatinine ratio (UACR) – ≤ 30 mg/g is normal, 30–300 mg/g denotes micro‑albuminuria, and > 300 mg/g indicates macro‑albuminuria. [14][15]

Liver Function

• Total bilirubin – Males have significantly higher concentrations than females; an isolated rise in direct (conjugated) bilirubin in infants warrants urgent evaluation for biliary obstruction or metabolic disease. 17
• Serum albumin – Serves as a marker of hepatic synthetic capacity; levels are influenced by nutrition, inflammation, and protein‑losing conditions. 17
• Alanine aminotransferase (ALT) – More liver‑specific than AST; initial screening panels should include ALT rather than both transaminases. 17
• Alkaline phosphatase (ALP) – Elevated patterns suggest cholestasis; age‑ and gender‑specific reference ranges are essential for accurate interpretation. 17
• Gamma‑glutamyl transferase (GGT) – Adding GGT to routine panels improves detection of liver disease but increases false‑positive results from 15 % to 30 %. 17
• Aspartate aminotransferase (AST) – Less liver‑specific; an AST : ALT ratio > 1 suggests advanced fibrosis or cirrhosis, whereas a ratio > 2 should prompt evaluation for non‑hepatic sources such as hemolysis or myopathy. 17

Hematology

• Hemoglobin – Anemia is defined as < 13.0 g/dL in males and < 12.0 g/dL in females; hemoglobin levels tend to decline when estimated glomerular filtration rate falls below 60 mL/min/1.73 m². 16

Lipids

• Low‑density lipoprotein (LDL) cholesterol – Target < 2.6 mmol/L for adults without atherosclerotic cardiovascular disease (ASCVD) and < 1.8 mmol/L for those with ASCVD. 13
• High‑density lipoprotein (HDL) cholesterol – Values ≤ 0.91 mmol/L are associated with increased risk of diabetes and cardiovascular disease. 13
• Triglycerides – Levels ≥ 2.22 mmol/L constitute a risk factor for diabetes. 13

Laboratory Standardization

• HbA1c assay certification – Methods must be NGSP‑certified and traceable to the DCCT reference assay; point‑of‑care devices are not appropriate for diagnostic use. [10][11]
• Verification of extreme HbA1c values – Results below the lower limit or > 15 % (140 mmol/mol) should be confirmed by repeat testing with an alternative analytical method. 11
• Albumin assay precision – Inter‑assay coefficient of variation should be < 15 % with reliable detection down to 2 mg/L. [14][15]
• Blood lead measurement – CLIA permits an analytical error of ± 4 µg/dL (± 40 ppb) for concentrations ≤ 20 µg/dL; tighter performance (± 2 µg/dL) reduces misclassification. 18

Specimen Handling (Urine)

• Spot urine albumin‑to‑creatinine ratio – Preferred over timed collections; first‑morning specimens are recommended in children to avoid orthostatic proteinuria. [14][15]
• Pre‑collection activity – Patients should avoid vigorous exercise for at least 24 hours before urine sampling. [14][15]
• Sample storage – Urine should be refrigerated for same‑day or next‑day analysis; a single freeze‑thaw is acceptable, but repeated cycles must be avoided. [14][15]

Interpretation Considerations

• Small HbA1c changes – Variations of ± 0.3 % may reflect analytical variability rather than true glycaemic change. 11
• Random glucose ≥ 140–180 mg/dL – Has high specificity (92–98 %) but low sensitivity (39–55 %) for diabetes; confirmatory testing is required. 9
• Fasting glucose variability – Day‑to‑day variance is 12–15 %; diagnosis of diabetes requires two separate elevated measurements. 9
• AST elevation in infants – An AST : ALT ratio > 2 should raise suspicion for hemolysis or myopathy rather than primary liver disease. 19

Disease‑Specific Confounders

• HbA1c reliability – Unreliable in anemia, hemoglobinopathies, end‑stage renal disease on dialysis, and any condition altering red‑cell lifespan. [13][11]
• Glycated albumin reliability – Affected by nephrotic syndrome, cirrhosis, abnormal thyroid function, and other disorders that modify albumin turnover. [12][13]
• Confirming persistent albuminuria – Repeat UACR in 2 of 3 samples, especially in patients with diabetes, to verify chronic albuminuria. [14][15]

Reporting Best Practices

• HbA1c reporting – Both percentage and mmol/mol units should be provided; reference intervals should stay within 4.5–5.5 % (26–37 mmol/mol), i.e., no more than ± 0.5 % from the mean of 5 % (31 mmol/mol). 11
• Urine albumin reporting – Express results as mg albumin per g creatinine with a normal reference ≤ 30 mg/g. [14][15]
• High proteinuria reporting – For spot urine protein‑to‑creatinine ratios of 500–1,000 mg/g, report total protein as mg protein per g creatinine; normal is < 200 mg/g. [14][15]